marimastat has been researched along with cgs 27023a in 3 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (cgs 27023a) | Trials (cgs 27023a) | Recent Studies (post-2010) (cgs 27023a) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 72 | 3 | 12 |
| Protein | Taxonomy | marimastat (IC50) | cgs 27023a (IC50) |
|---|---|---|---|
| Interstitial collagenase | Homo sapiens (human) | 0.031 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0297 | |
| Stromelysin-1 | Homo sapiens (human) | 0.0256 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0191 | |
| Lethal factor | Bacillus anthracis | 1.2 | |
| Neutrophil collagenase | Homo sapiens (human) | 0.0105 | |
| Collagenase 3 | Homo sapiens (human) | 0.0209 | |
| Matrix metalloproteinase-14 | Homo sapiens (human) | 0.023 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hande, KR; Nelson, AR; Rothenberg, ML | 1 |
| Eckhardt, SG; Hidalgo, M | 1 |
| Howes, JM; Laing, GD; Theakston, RD | 1 |
1 review(s) available for marimastat and cgs 27023a
| Article | Year |
|---|---|
Development of matrix metalloproteinase inhibitors in cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biphenyl Compounds; Clinical Trials as Topic; Drugs, Investigational; Enzyme Inhibitors; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Neoplasms; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Tetracycline; Tetracyclines; Thiophenes | 2001 |
2 other study(ies) available for marimastat and cgs 27023a
| Article | Year |
|---|---|
New drugs on the horizon: matrix metalloproteinase inhibitors.
Topics: Antineoplastic Agents; Azepines; Biphenyl Compounds; Humans; Hydroxamic Acids; Metalloendopeptidases; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Thiophenes | 1999 |
Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators.
Topics: Animals; Biphenyl Compounds; Chelating Agents; Chromatography, Gel; Chromatography, Liquid; Edetic Acid; Egtazic Acid; Ethylenediamines; Evaluation Studies as Topic; Hemorrhage; Hydroxamic Acids; Metalloproteases; Mice; Molecular Structure; Organic Chemicals; Phenylbutyrates; Protein Kinase Inhibitors; Pyrazines; Snake Bites; Statistics, Nonparametric; Sulfonamides; Viper Venoms | 2007 |